Exactech Lawsuit October 2026: the Billion-Dollar TPG Fight, 1,838 Pending Cases & What Your Claim Needs Now

The Exactech implant litigation has a new center of gravity: after the company's Chapter 11 plan was confirmed in September 2025, a litigation trust sued private equity owner TPG Capital in 2026. With 1,838 patient cases pending and no trial or settlement yet, the fight over failed knee, hip, and ankle implants now targets the money behind the company.

Key facts

  • 1,838 Exactech lawsuits were pending in federal multidistrict litigation (MDL 3044) as of October 2026, before Judge Nicholas G. Garaufis in New York.
  • More than 143,000 recalled implants are at issue — knee, hip, and ankle devices manufactured from 2004 through August 2021.
  • September 17, 2025: Exactech's Chapter 11 bankruptcy plan was confirmed; it took effect on October 31, 2025.
  • In 2026, the bankruptcy litigation trust sued TPG Capital — the private equity firm that acquired Exactech in 2018 — in a billion-dollar fraud action.
  • No trials and no approved patient settlements have occurred in MDL 3044; a Broadspire reimbursement program covers only money patients already spent.

What went wrong with the implants

The problem was the plastic — and the bag it came in. Exactech's joint replacements use polyethylene liners, the smooth cushion between metal components. The company packed those liners in defective vacuum-seal bags that let oxygen in; the oxygen oxidized the plastic before it ever reached an operating room. Oxidized polyethylene wears faster, cracks, sheds debris, and loosens — causing pain, bone loss, instability, and often revision surgery: a second operation to remove the failed implant and install a new one.

The FDA classified the recalls as Class II and lists them as open. They covered Optetrak, Optetrak Logic, and Truliant knee systems; Connexion GXL, MCS, Acumatch, and Novation hip liners; and Vantage ankle systems — devices implanted between 2004 and August 2021. If your joint replacement falls in that window and failed early, this litigation is about you.

Where the litigation stands

The federal cases were centralized in October 2022 as MDL No. 3044 — In re: Exactech Polyethylene Orthopedic Products Liability Litigation — in the Eastern District of New York. An MDL, or multidistrict litigation, is the federal coordinated proceeding: one judge handles shared discovery and pretrial rulings for cases filed nationwide, while each plaintiff keeps an individual claim.

The docket's defining feature is what has not happened: no bellwether trial has reached a verdict, and no patient settlement has been approved. Two early bellwether trials — the Tarloff and Larson cases — were once set for 2025, but the bankruptcy filing froze the calendar. Device mass torts resolve in a familiar sequence — coordinated discovery, test trials, settlement talks — visible in the hernia mesh litigation and the Bard PowerPort cases.

The bankruptcy chapter

In October 2024, Exactech filed for Chapter 11 bankruptcy as lawsuits mounted. Chapter 11 is reorganization, not disappearance: the company keeps operating while a court-supervised plan sorts out who gets paid. The automatic stay that accompanies bankruptcy paused the patient lawsuits cold.

The plan was confirmed on September 17, 2025 and took effect on October 31, 2025. Confirmation ended the limbo but not the litigation: the plan channeled claims into a litigation trust rather than paying plaintiffs directly. That trust now holds the claims against the company's former owners — which brings us to the billion-dollar question.

The billion-dollar TPG fight

TPG Capital, the private equity firm that acquired Exactech in 2018, is now the defendant that matters most. In 2026, the bankruptcy litigation trust sued TPG in a fraud action described as a billion-dollar case — alleging, in essence, that value was extracted from the company in ways that left injured patients with an empty pocket to collect from.

Why should a patient with a failed knee care about a fraud suit between financial entities? Because in bankrupt mass torts, the operating company's assets are rarely enough, and recovery follows the money. If the trust wins or settles against TPG, proceeds flow toward the patient claims it represents. That is what transformed this litigation in 2026: the case is no longer just about defective packaging — it is about whether the private equity owner helps fund the compensation. On how device cases value individual injuries, see our IVC filter lawsuit update, where individual verdicts — not averages — set the tone.

Broadspire is not a settlement

Exactech hired Broadspire to "settle" claims, and patients should understand what that word means here. Broadspire reimburses money you already spent — past medical bills tied to the failed implant. It does not cover future medical care, lost wages, or a free replacement device.

That distinction is everything. A revision surgery can mean months of recovery, time off work, and another replacement down the road. Accepting a reimbursement check for yesterday's bills without advice can complicate a claim for tomorrow's costs. Anyone contacted by Broadspire should consult an attorney experienced in the Exactech litigation before signing anything — the program is administrative, not a court-approved settlement of your legal rights.

Who qualifies and what to gather

The pattern is specific: a recalled Exactech device — Optetrak, Optetrak Logic, or Truliant knee; Connexion GXL, MCS, Acumatch, or Novation hip liner; or a Vantage ankle system — implanted between 2004 and August 2021, followed by premature failure: loosening, cracking, excessive wear, bone loss, or revision surgery.

Gather four things now: your implant card or surgical report showing the exact device model; records of the original implantation; records of the failure and any revision; and a symptom timeline. Device model matters enormously — the litigation rests on the oxidized-polyethylene theory, so proof of which liner you received is the foundation of the file. Implant cards tucked into discharge paperwork have saved more claims than any other single document.

What happens next

Three tracks run in parallel: the TPG fraud action, which will determine how much money sits behind patient compensation; the MDL, freed from the bankruptcy stay, moving toward bellwether trials that set settlement values; and the clock — statutes of limitations vary by state, and bankruptcy does not pause every deadline.

No one can honestly quote a settlement figure today: there are no verdicts and no approved settlements to base one on, and compensation varies widely by case. What is real is the trajectory — 1,838 pending cases, a confirmed plan, and a billion-dollar fight against the private equity owner. For plain-language explainers on how device mass torts move from recall to resolution, the Problem Solved channel covers complex litigation in everyday terms. If you carry a recalled Exactech implant, get a free case review now — before the next phase sets the terms without you.

Who Benefits From This — and Who Does Not

Patients with a recalled Exactech implant that failed early. If your knee, hip, or ankle device was implanted between 2004 and August 2021 and later loosened, cracked, or required revision surgery, start by requesting your operative report and checking your model against the recalled systems — Optetrak, Optetrak Logic, and Truliant knees; Connexion GXL, MCS, Acumatch, and Novation hip liners; and Vantage ankles.

Patients weighing the Broadspire program. Broadspire covers only money you already spent — not future care, lost wages, or a replacement implant — so do not sign its paperwork without legal advice first, and get a free case review to learn what a claim, rather than a reimbursement form, could cover.

Patients following where the money may come from. With 1,838 cases pending in MDL 3044 and no trial or approved settlement yet, the 2026 billion-dollar fraud action by the bankruptcy litigation trust against TPG Capital — the firm that acquired Exactech in 2018 — is the proceeding to watch, because any recovery would flow toward the patient claims the trust represents.

Who does not benefit. Patients whose implants were used as approved and still function well have no injury to claim, and anyone expecting an approved Exactech settlement today will be disappointed: none exists yet. Investors in the separate securities matter are not patient claimants either. For how device recalls are tracked in another product line, see our Edwards Sapien early-alert update for 2026.

Frequently asked questions

Has there been an Exactech settlement?

No. As of October 2026, no trials have occurred and no patient settlements have been approved in MDL 3044. A Broadspire program exists but covers only past out-of-pocket costs — not future care, lost wages, or a replacement implant.

Does the bankruptcy mean patients get nothing?

No. The Chapter 11 plan was confirmed in September 2025 and created a litigation trust holding patient claims. That trust sued TPG Capital in 2026 in a billion-dollar fraud action, aiming recovery at the private equity firm that acquired Exactech in 2018.

Which Exactech implants were recalled?

Optetrak, Optetrak Logic, and Truliant knee systems; Connexion GXL, MCS, Acumatch, and Novation hip liners; and Vantage ankle systems — manufactured from 2004 through August 2021 with polyethylene components affected by defective packaging.

What is the TPG lawsuit about?

The bankruptcy litigation trust alleges fraud against TPG Capital — essentially that value was extracted from the company, leaving injured patients too little to collect from. Any recovery would flow toward patient claims.

What does it cost to file an Exactech claim?

Case reviews are free, and firms work on contingency — paid only if you recover. Do not sign Broadspire paperwork without legal advice first.

Who benefits most from following the Exactech litigation?

Patients with a recalled Exactech implant from 2004 to August 2021 that failed early or required revision surgery — they are the core of the 1,838 pending cases in MDL 3044 — along with patients deciding whether Broadspire reimbursement or a full claim better fits their losses.

This article is general information about an ongoing litigation, not legal or medical advice. If you have concerns about an implanted device, speak with your doctor. For questions about your legal rights, consult a qualified attorney in your state.

Watch on YouTube

Problem Solved on YouTube